Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

August 31, 2024

Conditions

Bioequivalence Trial

Interventions

OTHER

Aximus capsules（test）

Aximus capsules test preparation

DRUG

Aximus capsules（reference）

Aximus capsules reference preparation

Trial Locations (1)

The Second Affiliated Hospital of WMU Phase l Clinical Trial Unit /Center Of Bioequivalence Study, Wenzhou

All Listed Sponsors

lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT06307132 - Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules | Biotech Hunter | Biotech Hunter